Literature DB >> 18683320

Generation and characterization of novel local and metastatic human neuroblastoma variants.

Ido Nevo1, Orit Sagi-Assif, Liat Edry Botzer, Dana Amar, Shelly Maman, Naam Kariv, Leonor E Leider-Trejo, Larissa Savelyeva, Manfred Schwab, Ilana Yron, Isaac P Witz.   

Abstract

Neuroblastoma (NB) is the most commonly occurring solid tumor in children. The disease usually arises in the adrenal medulla, and it is characterized by a remarkable heterogeneity in its progression. Most NB patients with an advanced disease have massive bone marrow infiltration at diagnosis. Lung metastasis represents a widely disseminated stage and is typically considered to be a terminal event. Much like other malignancies, NB progression is a complex, multistep process. The expression, function, and significance of the various factors involved in NB progression must be studied in relevant in vivo and in vitro models. Currently, models consisting of metastatic and nonmetastatic cell variants of the same genetic background exist for several types of cancer; however, none exists for NB. In the present study, we describe the generation of a NB metastasis model. SH-SY5Y and MHH-NB-11 NB cells were inoculated orthotopically into the adrenal glands of athymic nude mice. Neuroblastoma cells metastasizing to the lungs were isolated from mice bearing adrenal tumors. Lung metastatic variants were generated by repeated cycles of in vivo passage. Characterization of these variants included cellular morphology and immunophenotyping in vitro, aggressiveness in vivo, and various biologic parameters in vitro. The NB metastatic variant in each model displayed unique properties, and both metastatic variants demonstrated a metastatic phenotype in vivo. These reproducible models of human NB metastasis will serve as an unlimited source of transcriptomic and proteomic material. Such models can facilitate future studies on NB metastasis and the identification of novel NB biomarkers and targets for therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18683320      PMCID: PMC2504768          DOI: 10.1593/neo.08402

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  54 in total

1.  In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice.

Authors:  C J Bruns; M T Harbison; H Kuniyasu; I Eue; I J Fidler
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

2.  Differences in CXCR4-mediated signaling in B cells.

Authors:  Elena Palmesino; Barbara Moepps; Peter Gierschik; Marcus Thelen
Journal:  Immunobiology       Date:  2006-04-18       Impact factor: 3.144

Review 3.  Yin-yang activities and vicious cycles in the tumor microenvironment.

Authors:  Isaac P Witz
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

Review 4.  The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.

Authors:  Christiane Brahimi-Horn; Jacques Pouysségur
Journal:  Bull Cancer       Date:  2006-08       Impact factor: 1.276

Review 5.  Cysteine cathepsins: multifunctional enzymes in cancer.

Authors:  Mona Mostafa Mohamed; Bonnie F Sloane
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

6.  Involvement of Hif-1 in desferrioxamine-induced invasion of glioblastoma cells.

Authors:  Anja Elstner; Nikola Holtkamp; Andreas von Deimling
Journal:  Clin Exp Metastasis       Date:  2007-03-15       Impact factor: 5.150

Review 7.  Regulation of angiogenesis by hypoxia-inducible factor 1.

Authors:  Kiichi Hirota; Gregg L Semenza
Journal:  Crit Rev Oncol Hematol       Date:  2006-05-22       Impact factor: 6.312

Review 8.  Mechanisms of invasion and metastasis in human neuroblastoma.

Authors:  Tasnim Ara; Yves A DeClerck
Journal:  Cancer Metastasis Rev       Date:  2006-12       Impact factor: 9.264

Review 9.  Hypoxia-driven selection of the metastatic phenotype.

Authors:  Richard Sullivan; Charles H Graham
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

Review 10.  The hypoxic tumour microenvironment and metastatic progression.

Authors:  Patrick Subarsky; Richard P Hill
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more
  10 in total

1.  Lung-residing metastatic and dormant neuroblastoma cells.

Authors:  Liat Edry Botzer; Shelly Maman; Orit Sagi-Assif; Tzipi Meshel; Ido Nevo; Tobias Bäuerle; Ilana Yron; Isaac P Witz
Journal:  Am J Pathol       Date:  2011-05-03       Impact factor: 4.307

2.  Dinosaurs and ancient civilizations: reflections on the treatment of cancer.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

3.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

4.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

5.  TL-118 and gemcitabine drug combination display therapeutic efficacy in a MYCN amplified orthotopic neuroblastoma murine model--evaluation by MRI.

Authors:  Chani Komar-Stossel; Eitan Gross; Elia Dery; Nathalie Corchia; Karen Meir; Iris Fried; Rinat Abramovitch
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

6.  Hexokinase 2 is a determinant of neuroblastoma metastasis.

Authors:  Liat Edry Botzer; Shelly Maman; Orit Sagi-Assif; Tsipi Meshel; Ido Nevo; Ilana Yron; Isaac P Witz
Journal:  Br J Cancer       Date:  2016-03-17       Impact factor: 7.640

7.  CCR4 is a determinant of melanoma brain metastasis.

Authors:  Anat Klein; Orit Sagi-Assif; Tsipi Meshel; Alona Telerman; Sivan Izraely; Shlomit Ben-Menachem; Jagadeesh Bayry; Diego M Marzese; Shuichi Ohe; Dave S B Hoon; Neta Erez; Isaac P Witz
Journal:  Oncotarget       Date:  2017-05-09

8.  Decellularized In Vitro Capillaries for Studies of Metastatic Tendency and Selection of Treatment.

Authors:  Outi Huttala; Desiree Loreth; Synnöve Staff; Minna Tanner; Harriet Wikman; Timo Ylikomi
Journal:  Biomedicines       Date:  2022-01-26

9.  PHOX2B is a suppressor of neuroblastoma metastasis.

Authors:  Osnat Naftali; Shelly Maman; Tsipi Meshel; Orit Sagi-Assif; Ravit Ginat; Isaac P Witz
Journal:  Oncotarget       Date:  2016-03-01

10.  The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y.

Authors:  Simon Auer; Mark Rinnerthaler; Johannes Bischof; Maria Karolin Streubel; Hannelore Breitenbach-Koller; Roland Geisberger; Elmar Aigner; Janne Cadamuro; Klaus Richter; Mentor Sopjani; Elisabeth Haschke-Becher; Thomas Klaus Felder; Michael Breitenbach
Journal:  Front Oncol       Date:  2017-05-31       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.